0001209191-19-018640.txt : 20190311 0001209191-19-018640.hdr.sgml : 20190311 20190311203546 ACCESSION NUMBER: 0001209191-19-018640 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190308 FILED AS OF DATE: 20190311 DATE AS OF CHANGE: 20190311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cancelmi Daniel J CENTRAL INDEX KEY: 0001396106 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07293 FILM NUMBER: 19673716 MAIL ADDRESS: STREET 1: 13737 NOEL ROAD STREET 2: SUITE 100 CITY: DALLAS STATE: TX ZIP: 75240 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TENET HEALTHCARE CORP CENTRAL INDEX KEY: 0000070318 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 952557091 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 BUSINESS PHONE: 469-893-2200 MAIL ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/ DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-08 0 0000070318 TENET HEALTHCARE CORP THC 0001396106 Cancelmi Daniel J 1445 ROSS AVENUE SUITE 1400 DALLAS TX 75202 0 1 0 0 Chief Financial Officer Common Stock 2019-03-08 4 M 0 12027 A 250588 D Common Stock 2019-03-08 4 F 0 4733 27.17 D 245855 D Common Stock 2019-03-08 4 M 0 15226 A 261081 D Common Stock 2019-03-08 4 F 0 5992 27.17 D 255089 D 2016 March Restricted Stock Units 2019-03-08 4 M 0 12027 0.00 D Common Stock 12027 0 D 2016 March Performance-Based Restricted Stock Units 2019-03-08 4 M 0 15226 0.00 D Common Stock 15226 0 D As previously reported, on March 10, 2016, the reporting person received a grant of 36,079 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 10, 2017, resulting in the settlement of 12,026 shares of common stock. The second vesting date occurred on March 9, 2018 (the business day prior to the anniversary date, which fell on a weekend), resulting in the settlement of 12,026 shares of common stock. The third vesting date occurred on March 8, 2019 (the business day prior to the anniversary date, which fell on a weekend), resulting in the settlement of the remaining 12,027 shares of common stock, as shown in Table I. Restricted stock units convert into common stock on a one-for-one basis. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. As previously reported, on March 10, 2016, the reporting person received a target grant of 36,079 performance-based restricted stock units that were subject to the Company's achievement of specified performance goals for the three year period that ended on December 31, 2018. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance goals were achieved in part, and 42.2% of the target grant was awarded; therefore, 15,226 restricted stock units vested on March 8, 2019 (the business day prior to the third anniversary of the date of grant, which fell on a weekend), resulting in the settlement of 15,226 shares of common stock, as shown in Table I. Restricted stock units are settled in shares of the Company's common stock upon vesting. Anthony L. Shoemaker, as Attorney-in-Fact for Daniel J. Cancelmi 2019-03-11